Crosstalk between triple negative breast cancer and microenvironment

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• Triple-negative breast cancer (TNBC) lacks targeted therapies, significantly impacting patient survival rates.
• The tumor microenvironment (TME) is a critical factor in TNBC development and progression.
• Current treatment advancements have not substantially improved overall survival for TNBC patients.

Purpose of the Study:

• To review recent progress in understanding TNBC biology.
• To define the mechanisms underlying current and emerging TNBC therapies.
• To identify potential therapeutic strategies to overcome TNBC challenges.

Main Methods:

• Literature review of preclinical and clinical studies on TNBC.
• Analysis of research on the role of the tumor microenvironment in TNBC.
• Synthesis of information on therapeutic strategies and their mechanisms.

Main Results:

• TNBC remains a significant clinical challenge with limited therapeutic options.
• The TME critically influences TNBC progression and treatment response.
• Understanding TNBC mechanisms is crucial for developing effective therapies.

Conclusions:

• Effective therapies for TNBC are urgently needed.
• Targeting the TME presents a promising strategy for TNBC treatment.
• Further research into TNBC mechanisms can guide the development of novel therapeutic approaches.